SARS-Cov-2 has spread rapidly throughout the world, but with significant and unexplainable differences between countries. The real-time polymerase chain reaction (RT-PCR) test performed on nasopharyngeal swabs was widely used to detect the virus, with antibody testing also showing specific IgG/IgM antibodies against SARS-CoV-2. Although the SARS-CoV-2 pathogen is highly contagious, neonates born to women with asymptomatic or symptomatic COVID‐19 are rarely infected with the virus.
This special issue aims to implement current knowledge of diagnostic, prognostic and therapeutic advances to achieve best management of pregnant and lactating patients with COVID-19, as well as their newborns. Research papers on maternal-fetal antibody status and on obstetric outcomes from COVID-19 during pregnancy are encouraged.
Dr. Federica Perelli
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.